Sensei Biotherapeutics, Inc.
SNSE
$21.45
$0.452.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -52.87% | -13.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.86% | -6.82% | |||
| Operating Income | 32.86% | 6.82% | |||
| Income Before Tax | -3.24% | 7.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.24% | 7.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.24% | 7.44% | |||
| EBIT | 32.86% | 6.82% | |||
| EBITDA | 33.09% | 6.81% | |||
| EPS Basic | -3.23% | 7.47% | |||
| Normalized Basic EPS | 31.00% | 6.73% | |||
| EPS Diluted | -3.23% | 7.47% | |||
| Normalized Diluted EPS | 31.00% | 6.73% | |||
| Average Basic Shares Outstanding | 0.01% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||